The Latest in Peritoneal Dialysis 2013
DOI: 10.5772/55964
|View full text |Cite
|
Sign up to set email alerts
|

Inflammation in Peritoneal Dialysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2013
2013
2013
2013

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 107 publications
(118 reference statements)
0
2
0
Order By: Relevance
“…There are potential therapeutic options to minimize peritoneal inflammation in PD patients, but yet need extensive research for further confirmation [151]. Acute peritonitis may be prevented by the use of chemokine receptor blockers, mast cell stabilizers or corticosteroid to block excessive macrophage activity.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…There are potential therapeutic options to minimize peritoneal inflammation in PD patients, but yet need extensive research for further confirmation [151]. Acute peritonitis may be prevented by the use of chemokine receptor blockers, mast cell stabilizers or corticosteroid to block excessive macrophage activity.…”
Section: Discussionmentioning
confidence: 99%
“…Regression analysis revealed that both the MMP-7 and TIMP-1, are excellent predictors of cellular stress in dialyzed patients using HSP-27 as the marker [125]. The number of mast cells is increased in PD patients [126], and mast cell tryptase is a serine protease implicated in promoting angiogenesis and fibrosis [126,127].…”
Section: Proteolytic Enzymesmentioning
confidence: 99%